Catherine Shaffer

In a small validation set, the model was able to make accurate predictions about patient outcomes using routinely collected patient data.

A foundation model built with the GigaPath algorithm outperformed other such pathology models in cancer subtyping and other prediction tasks.

The firm is engaging with regulators about its recently validated Ataraxis Breast test, which it hopes to make available for clinical use next year.

In the absence of head-to-head studies, oncologists are looking across pivotal trials and are encouraged by Itovebi's safety and efficacy versus Piqray.

Hollings researchers will develop AI-driven tools to better match cancer patients to marketed therapies and clinical trials.

The firms will initially develop a tool to identify NSCLC patients with EGFR mutations who can benefit from targeted therapy.

Transfeminine patients have PSA levels 50 times lower than similarly aged cisgender men, obscuring interpretation of test results.

Several new studies appear to confirm the test's potential to prevent overtreatment of melanoma patients while identifying those at high risk.

Doctors are using limited guidance on screening and treatment approaches for transgender patients predisposed to cancer while considering patient preferences and treatment goals.

About 500 children worldwide have received the gene therapy, including some families traveling abroad to gain access to it.